Innovations in Probiotics and Clinical Applications – Track 14 | WCCMR 2026
October 01–03, 2026 | Dubai, UAE
The 10th World Congress on Clinical and Medical Research (WCCMR 2026) stands as a premier international platform dedicated to advancing excellence in clinical practice, translational medicine, and healthcare innovation. Scheduled to take place from October 01–03, 2026, in Dubai, UAE, this landmark congress will bring together researchers, clinicians, academicians, healthcare professionals, policymakers, and industry leaders from across the globe.
As part of its comprehensive scientific agenda, Track 14: Probiotics invites the global scientific community to contribute cutting-edge research, clinical insights, and innovative applications that shape the evolving landscape of probiotics, gut microbiota, and microbiome-based therapies. This track highlights the growing role of probiotics in disease prevention, therapeutic interventions, and overall human health.
About the 10th World Congress on Clinical and Medical Research (WCCMR 2026)
WCCMR 2026 is designed to foster interdisciplinary collaboration and knowledge exchange across the full spectrum of clinical and medical sciences. Now in its tenth edition, the congress has built a strong reputation for delivering high-quality scientific content, featuring keynote addresses from internationally renowned experts, plenary sessions, panel discussions, workshops, poster presentations, and industry exhibitions.
Promote evidence-based clinical and medical research
Encourage translational approaches that bridge research and clinical practice
Support innovation in diagnostics, therapeutics, and healthcare delivery
Provide a global networking platform for academia, industry, and healthcare organizations
Dubai, a global hub for medical innovation and international conferences, offers an ideal setting for WCCMR 2026, combining world-class infrastructure with easy global accessibility.
Track 14: Probiotics – Scope and Scientific Focus
Track 14: Probiotics is dedicated to exploring the scientific, clinical, and commercial dimensions of probiotics and microbiome research. With increasing evidence highlighting the critical role of gut microbiota in health and disease, probiotics have emerged as a key area of interest across multiple medical specialties.
This track focuses on both foundational research and real-world clinical applications, emphasizing safety, efficacy, regulatory perspectives, and future directions.
Key Themes and Topics Include:
Probiotic mechanisms of action and host–microbe interactions
Gut microbiota composition and its role in human health
Probiotics in gastrointestinal disorders
Probiotics in metabolic, cardiovascular, and immune-related diseases
Role of probiotics in mental health and the gut–brain axis
Pediatric and geriatric probiotic applications
Probiotics in women’s health
Synbiotics, prebiotics, and postbiotics
Personalized nutrition and microbiome-based therapies
Clinical trials, safety, and regulatory considerations
Advances in probiotic formulation, delivery systems, and stability
Industrial and pharmaceutical innovations in probiotic development
Through these themes, Track 14 aims to present a comprehensive overview of current progress while identifying challenges and opportunities for future research.
Importance of Probiotics in Modern Clinical and Medical Research
The global focus on preventive healthcare and personalized medicine has significantly elevated the importance of probiotics. Research has demonstrated that gut microbiota influences immunity, metabolism, inflammation, and even neurological function. Probiotics offer a promising, non-invasive, and cost-effective approach to managing and preventing various chronic and lifestyle-related diseases.
At WCCMR 2026, Track 14 will emphasize:
Evidence-based clinical outcomes
Translational research bridging laboratory findings to patient care
Multidisciplinary perspectives involving clinicians, microbiologists, nutritionists, and industry experts
This makes the track highly relevant for researchers and practitioners seeking to integrate microbiome science into clinical practice.
Call for Abstracts – Track 14: Probiotics
The Call for Abstracts for Track 14: Probiotics invites original research papers, clinical studies, systematic reviews, case reports, and innovative concepts. Submissions should demonstrate scientific rigor, originality, and relevance to probiotics and microbiome science.
Abstract Submission Guidelines:
Abstracts must be written in clear, professional English
Submissions should highlight objectives, methodology, results, and conclusions
Research may be basic, translational, or clinical in nature
Industry-focused and regulatory studies are also encouraged
All submitted abstracts will undergo a peer-review process by the scientific committee. Accepted abstracts will be scheduled for oral or poster presentations and published in the conference proceedings.
For abstract-related queries: WhatsApp: https://wa.me/+971551792927
Registration Opportunities
Registration for WCCMR 2026 provides participants with access to all scientific sessions, keynote lectures, panel discussions, networking events, and conference materials. Early registration is encouraged to take advantage of discounted rates.
Access to high-impact scientific sessions
Opportunity to present research to a global audience
Networking with international experts and industry leaders
Certificate of participation and presentation
Professional recognition and career advancement
Registration categories are available for researchers, clinicians, academicians, students, and industry professionals.
Exhibitors and Industry Participation
WCCMR 2026 also welcomes exhibitors and sponsors from the pharmaceutical, biotechnology, nutraceutical, diagnostic, and healthcare sectors. The exhibition provides a strategic platform to showcase products, technologies, and services to a targeted global audience.
Direct engagement with researchers and clinicians
Brand visibility at an international scientific congress
Product demonstrations and lead generation
Opportunities for partnerships and collaborations
Companies specializing in probiotics, microbiome diagnostics, functional foods, supplements, and healthcare innovations are especially encouraged to participate.
Keynote Sessions – Track 14: Probiotics
Track 14 will feature keynote lectures by leading experts in microbiome science and clinical nutrition. These sessions will address emerging trends, future therapeutic applications, and regulatory frameworks shaping the probiotic industry.
The Future of Probiotics in Precision Medicine
Gut Microbiota as a Therapeutic Target
Clinical Evidence and Regulatory Pathways for Probiotics
Innovations in Microbiome-Based Therapies
Why Attend WCCMR 2026 – Track 14: Probiotics
Participation in Track 14 offers a unique opportunity to:
Present and publish your research
Gain insights into global probiotic research trends
Learn from interdisciplinary experts
Expand professional networks
Contribute to advancements in patient-centered care
Clinical and Medical Research Conference 2026, WCCMR 2026 Dubai, Probiotics Conference, Gut Microbiota Research, Microbiome Clinical Applications, Probiotics Abstract Submission, Medical Research Conference Dubai, Clinical Research Congress, Probiotics and Gut Health, Microbiome Innovation Conference